関連する実験動画
Updated: Feb 14, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
6.0K
様々なE3リガゼの探査によってKRAS-G12Dの退廃因子の発見
Hyerin Yim1, Xiangyang Song1, Yue Zhong1
1Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Science, Oncological Science and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
European journal of medicinal chemistry
|February 12, 2026
まとめ
KRAS-G12Dを標的とする新しいPROTACは,CRBNとVHL E3リガゼを使用して開発され,強力な劣化を示しています. E3リガゼの選択は,効果的なKRAS-G12D分解剤の開発に不可欠です.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 薬用化学 薬用化学について
背景:
- PROTEOLYSIS TARGETING CHIMERA (PROTAC) 技術は,標的型タンパク質の分解を可能にしています.
- ほとんどのPROTACは,ヒトゲノムの多数の選択肢にもかかわらず,限られたE3リガゼ (CRBN,VHL) を利用しています.
- 新種のKRAS-G12D退廃剤の開発は,がん治療において極めて重要です.
研究 の 目的:
- 多様なE3リガスを採用する新しいKRAS-G12D分解剤を設計・合成する.
- CRBN,VHL,DCAF1,KLHDC2.2を使用したKRAS-G12D退廃剤の有効性を評価する.
- PROTAC媒介によるKRAS-G12Dの分解に影響を与える重要な要因を特定する.
主な方法:
- KRAS-G12D劣化剤の構造-活性関係 (SAR) 研究.
- KRAS-G12D阻害剤MRTX1133.3をベースにしたPROTACの合成
- タンパク質の分解,下流信号抑制,および反増殖活性の評価.
主要な成果:
- 2つの強力なKRAS-G12D劣化剤,30 (CRBNベースの) と41 (VHLベースの) が特定されました.
- デグラダー43は,劣化と反増殖効果の改善を示した.
- KLHDC2およびDCAF1ベースの退廃剤は,E3リガースの互換性問題を示唆する,限られた有効性を示しました.
結論:
- CRBNとVHLは,KRAS-G12D PROTACの開発のための効果的なE3結合体である.
- E3リガゼの選択は,PROTACの有効性に大きな影響を与えます.
- 最適化された PROTAC 設計は,KRAS-G12D をターゲットにするのに不可欠です.
関連する概念動画
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Regulated Protein Degradation
3.2K
3.2K
Proteins: From Genes to Degradation
14.6K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.6K
Proteins: From Genes to Degradation
4.6K
4.6K
Drug Discovery: Overview
11.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.9K
Role of Matrix Metalloproteases in Degradation of ECM
3.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K

